BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6600950)

  • 21. Specificity of lactoferrin as an inhibitor of granulocyte-macrophage colony-stimulating activity production from fetal mouse liver cells.
    Zucali JR; Broxmeyer HE; Ulatowski JA
    Blood; 1979 Oct; 54(4):951-4. PubMed ID: 314314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence in vivo of murine colony-stimulating factor-1 on myeloid progenitor cells in mice recovering from sublethal dosages of cyclophosphamide.
    Broxmeyer HE; Williams DE; Cooper S; Waheed A; Shadduck RK
    Blood; 1987 Mar; 69(3):913-8. PubMed ID: 3545324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of T-lymphocytes and lactoferrin on the survival-promoting effects of IL-1 and IL-6 on human bone marrow granulocyte-macrophage and erythroid progenitor cells.
    Hangoc G; Falkenburg JH; Broxmeyer HE
    Exp Hematol; 1991 Aug; 19(7):697-703. PubMed ID: 1893956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice.
    Broxmeyer HE; Cooper S; Hague N; Benninger L; Sarris A; Cornetta K; Vadhan-Raj S; Hendrie P; Mantel C
    Ann Hematol; 1995 Nov; 71(5):235-46. PubMed ID: 7492626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactoferrin acts on I-A and I-E/C antigen+ subpopulations of mouse peritoneal macrophages in the absence of T lymphocytes and other cell types to inhibit production of granulocyte-macrophage colony stimulatory factors in vitro.
    Broxmeyer HE; Platzer E
    J Immunol; 1984 Jul; 133(1):306-14. PubMed ID: 6144710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased granulopoiesis after sequential administration of transforming growth factor-beta 1 and granulocyte-macrophage colony-stimulating factor.
    Hestdal K; Jacobsen SE; Ruscetti FW; Longo DL; Boone TC; Keller JR
    Exp Hematol; 1993 Jun; 21(6):799-805. PubMed ID: 8500577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1.
    Gallicchio VS; Shedlofsky SI; Swim AT; Robinson JM; Hulette BC; Messino MJ; Doukas MA
    J Biol Response Mod; 1989 Aug; 8(4):422-39. PubMed ID: 2666587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of myleran on murine hemopoiesis. I. Granulocytic cell line specificity of action on progenitor cells.
    Delmonte L
    Cell Tissue Kinet; 1978 Jul; 11(4):347-58. PubMed ID: 308393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specificity and modulation of the action of lactoferrin, a negative feedback regulator of myelopoiesis.
    Broxmeyer HE; DeSousa M; Smithyman A; Ralph P; Hamilton J; Kurland JI; Bognacki J
    Blood; 1980 Feb; 55(2):324-33. PubMed ID: 6965457
    [No Abstract]   [Full Text] [Related]  

  • 30. In situ radiation sensitivity of recombinant human granulocyte colony-stimulating factor-recruited murine circulating blood and bone marrow progenitors (colony-forming unit [CFU]-granulocyte-macrophage and CFU-megakaryocyte): evidence for possible biologic differences between mobilized blood and bone marrow.
    Scheding S; Media JE; KuKuruga MA; Nakeff A
    Blood; 1996 Jul; 88(2):472-8. PubMed ID: 8695794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of organ-specific loss of insulin-like growth factor-I production on murine hematopoiesis.
    Welniak LA; Karas M; Yakar S; Anver MR; Murphy WJ; LeRoith D
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):32-9. PubMed ID: 14752777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo modulation of myelopoiesis by prostaglandin E2. IV. Prostaglandin E2 induction of myelopoietic inhibitory activity.
    Gentile PS; Pelus LM
    J Immunol; 1988 Oct; 141(8):2714-20. PubMed ID: 3171182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of prostaglandin biosynthesis in intact mice dramatically augments the expansion of committed myeloid progenitor cells (colony-forming units-granulocyte, macrophage) after acute administration of recombinant human IL-1 alpha.
    Pelus LM
    J Immunol; 1989 Dec; 143(12):4171-9. PubMed ID: 2592770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibody (II2C) to human lactoferrin inactivates the myelopoietic suppressive effect of human lactoferrin in vitro.
    Sledge GW; Bicknell DC; Harris EL; Zegarra G; Broxmeyer HE
    Exp Hematol; 1986 Jun; 14(5):333-7. PubMed ID: 3709705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lactoferrin: affinity purification from human milk and polymorphonuclear neutrophils using monoclonal antibody (II 2C) to human lactoferrin, development of an immunoradiometric assay using II 2C, and myelopoietic regulation and receptor-binding characteristics.
    Broxmeyer HE; Bicknell DC; Gillis S; Harris EL; Pelus LM; Sledge GW
    Blood Cells; 1986; 11(3):429-46. PubMed ID: 3017479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipopolysaccharide reciprocally alters the stromal cell-regulated positive and negative balance between myelopoiesis and B lymphopoiesis in C57BL/6 mice.
    Taki M; Tsuboi I; Harada T; Naito M; Hara H; Inoue T; Aizawa S
    Biol Pharm Bull; 2014; 37(12):1872-81. PubMed ID: 25451836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transferrin, derived from an OKT8-positive subpopulation of T lymphocytes, suppresses the production of granulocyte-macrophage colony-stimulatory factors from mitogen-activated T lymphocytes.
    Broxmeyer HE; Lu L; Bognacki J
    Blood; 1983 Jul; 62(1):37-50. PubMed ID: 6602633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mast cell growth factor (C-kit ligand) in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3: in vivo hemopoietic effects in irradiated mice compared to in vitro effects.
    Patchen ML; Fischer R; MacVittie TJ; Seiler FR; Williams DE
    Biotherapy; 1993; 7(1):13-26. PubMed ID: 7520725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.